Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneity in statin responses explained by variation in the human gut microbiome
Tomasz Wilmanski, Sergey A. Kornilov, Christian Diener, et al.
Med (2022) Vol. 3, Iss. 6, pp. 388-405.e6
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Understanding the molecular mechanisms of statin pleiotropic effects
Charles German, James K. Liao
Archives of Toxicology (2023) Vol. 97, Iss. 6, pp. 1529-1545
Open Access | Times Cited: 64
Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective
Mireia Vallès-Colomer, Cristina Menni, Sarah Berry, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 551-561
Closed Access | Times Cited: 53
Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease
Xin Zhou, Xiaotao Shen, Jethro S. Johnson, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 4, pp. 506-526.e9
Open Access | Times Cited: 49
Roles of the gut microbiome in weight management
Rachel N. Carmody, Jordan E. Bisanz
Nature Reviews Microbiology (2023) Vol. 21, Iss. 8, pp. 535-550
Closed Access | Times Cited: 42
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner
Jianqing She, Gulinigaer Tuerhongjiang, Manyun Guo, et al.
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 408-421.e5
Open Access | Times Cited: 24
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Rima Chakaroun, Lisa Olsson, Fredrik Bäckhed
Nature Reviews Cardiology (2022) Vol. 20, Iss. 4, pp. 217-235
Closed Access | Times Cited: 69
Perspective: Leveraging the Gut Microbiota to Predict Personalized Responses to Dietary, Prebiotic, and Probiotic Interventions
Sean M. Gibbons, Thomas Gurry, Johanna W. Lampe, et al.
Advances in Nutrition (2022) Vol. 13, Iss. 5, pp. 1450-1461
Open Access | Times Cited: 48
Exploring the potential impact of probiotic use on drug metabolism and efficacy
Carmen Purdel, Anca Ungurianu, Ines Adam-Dima, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114468-114468
Open Access | Times Cited: 33
Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease
Clara Caenepeel, Gwen Falony, Kathleen Machiels, et al.
Gastroenterology (2023) Vol. 166, Iss. 3, pp. 483-495
Open Access | Times Cited: 32
Digesting the complex metabolic effects of diet on the host and microbiome
Rachel N. Carmody, Krista A Varady, Peter J. Turnbaugh
Cell (2024) Vol. 187, Iss. 15, pp. 3857-3876
Closed Access | Times Cited: 13
Approach to the diagnosis and management of dysbiosis
Kannayiram Alagiakrishnan, Joao Morgadinho, Tyler Halverson
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 12
The transition from genomics to phenomics in personalized population health
James T. Yurkovich, Simon J. Evans, Noa Rappaport, et al.
Nature Reviews Genetics (2023) Vol. 25, Iss. 4, pp. 286-302
Closed Access | Times Cited: 22
The gut microbiota in thrombosis
My Phung Khuu, Nadja Paeslack, Olga Dremova, et al.
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 7
Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)
Timo Strandberg, Petri T. Kovanen, Donald M. Lloyd‐Jones, et al.
The Lancet (2024)
Closed Access | Times Cited: 5
Incorporating metabolic activity, taxonomy and community structure to improve microbiome-based predictive models for host phenotype prediction
Mahsa Monshizadeh, Yuzhen Ye
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Droplet microfluidics: unveiling the hidden complexity of the human microbiome
Yibin Xu, Zhiyi Wang, Caiming Li, et al.
Lab on a Chip (2025)
Closed Access
Clinical translation of microbiome research
Jack A. Gilbert, Meghan B. Azad, Fredrik Bäckhed, et al.
Nature Medicine (2025)
Closed Access
Healthy aging and the human gut microbiome: why we cannot just turn back the clock
Tomasz Wilmanski, Sean M. Gibbons, Nathan D. Price
Nature Aging (2022) Vol. 2, Iss. 10, pp. 869-871
Open Access | Times Cited: 18
The Bidirectional Relationship Between Cardiovascular Medications and Oral and Gut Microbiome Health: A Comprehensive Review
Gangani Dharmarathne, Samia Kazi, Shalinie King, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2246-2246
Open Access | Times Cited: 3
Lipid metabolism correction with statins and probiotics
Н. В. Барышникова, V. M. L’Nyavina, Yury P. Uspenskiy, et al.
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 161-174
Closed Access
Gut microbiota as predictors of recurrent cardiovascular events: challenges and future directions
Barbara J. H. Verhaar, Max Nieuwdorp, Bert‐Jan H. van den Born
European Heart Journal (2025)
Closed Access
Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease
Mykhailo Buchynskyi, Iryna Kamyshna, Iryna Halabitska, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Development of an LC-MS method for the determination of simvastatin and its hydroxy acid form in muscle tissue and method application
Ewa Paszkowska, Karolina Pietrowska, Steen Larsen, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322808-e0322808
Open Access
Role of Gut Microbiota in Statin-Associated New-Onset Diabetes—A Cross-Sectional and Prospective Analysis of the FINRISK 2002 Cohort
Kari Koponen, Oleg Kambur, Bijoy Joseph, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 44, Iss. 2, pp. 477-487
Open Access | Times Cited: 9
Prenatal exposures to endocrine disrupting chemicals: The role of multi-omics in understanding toxicity
Margaret H. Rabotnick, Jessa Ehlinger, Ariana Haidari, et al.
Molecular and Cellular Endocrinology (2023) Vol. 578, pp. 112046-112046
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top